Process for preparing sphingolipids

US11939612B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11939612-B2
Application numberUS-202117497484-A
CountryUS
Kind codeB2
Filing dateOct 8, 2021
Priority dateMar 29, 2018
Publication dateMar 26, 2024
Grant dateMar 26, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides a process for preparing sphingolipids, compositions comprising sphingolipids and further components, and for the use of the compositions.

First claim

Opening claim text (preview).

The invention claimed is: 1. A cosmetic formulation comprising a composition, comprising: A) at least one sphingolipid of the general formula I B) at least one lysosphingolipid of the general formula II C) at least one triglyceride of the general formula III D) at least one diglyceride of the general formula IV E) at least one monoglyceride of the general formula V where R 1 is the same or different and independently represents a linear or branched alkyl chain having 2 to 55 carbon atoms that optionally contains one or more multiple bonds and/or aromatic or heteroaromatic rings, is optionally interrupted by oxygen atoms or ester or amide functionalities and is optionally substituted by at least one further group selected from alkyl, hydroxyl, keto or amine groups, R 2 is the same or different and independently represents H, phosphocholine, serine, ethanolamine or a sugar, and X represents CH═CH, CH 2 —CH 2 or CH 2 —HCOH, wherein based on the total composition, the components are present as follows: A) 30% by weight to 98% by weight, B) 0.01% by weight to 60% by weight, C) 0.01% by weight to 60% by weight, D) 0.1% by weight to 30% by weight, E) 0.1% by weight to 30% by weight. 2. A cosmetic formulation comprising a composition comprising: A) at least one sphingolipid of the general formula I B) at least one lysosphingolipid of the general formula II C) at least one triglyceride of the general formula III D) at least one diglyceride of the general formula IV E) at least one monoglyceride of the general formula V where R 1 is the same or different and independently represents a linear or branched alkyl chain having 2 to 55 carbon atoms that optionally contains one or more multiple bonds and/or aromatic or heteroaromatic rings, is optionally interrupted by oxygen atoms or ester or amide functionalities and is optionally substituted by at least one further group selected from alkyl, hydroxyl, keto or amine groups, R 2 is the same or different and independently represents H, phosphocholine, serine, ethanolamine or a sugar, and X represents CH═CH, CH 2 —CH 2 or CH 2 —HCOH, wherein the components are present in the composition as follows: A) 30 parts by weight to 98 parts by weight, B) 0.01 part by weight to 60 parts by weight, D) 0.1 part by weight to 30 parts by weight, E) 0.1 part by weight to 30 parts by weight, and, based on the overall composition, C) 60% by weight to 98% by weight. 3. The formulation according to claim 1 , wherein R 2 ═H and X═CH 2 —CH 2 and R 1 is selected from the group consisting of cocyol radicals, palmitoyl radicals, oleyl radicals, linoleyl radicals, linolenyl radicals, ricinoyl radicals, stearyl radicals, erucyl radicals and polyunsaturated fatty acyl radicals. 4. The formulation according to claim 1 , wherein R 2 is selected from the group consisting of sugar and H, and X is CH 2 —CH 2 wherein based on the total composition, the components are present as follows: A) 50% by weight to 90% by weight, B) 0.01% by weight to 45% by weight, C) 0.01% by weight to 45% by weight, D) 0.1% by weight to 20% by weight, E) 0.1% by weight to 20% by weight. 5. The formulation according to claim 1 , wherein R 2 is H, and X is CH 2 —CH 2 wherein based on the total composition, the components are present as follows: A) 65% by weight to 85% by weight, B) 0.5% by weight to 10% by weight, C) 0.01% by weight to 10% by weight, D) 2% by weight to 15% by weight, and E) 2% by weight to 15% by weight. 6. The formulation according to claim 2 , wherein R 2 ═H and X═CH 2 —CH 2 and R 1 is selected from the group consisting of cocyol radicals, palmitoyl radicals, oleyl radicals, linoleyl radicals, linolenyl radicals, ricinoyl radicals, stearyl radicals, erucyl radicals and polyunsaturated fatty acyl radicals. 7. The formulation according to claim 2 , wherein R 2 is selected from the group consisting of sugar and H, and X is CH 2 —CH 2 — wherein based on the total composition, the components are present as follows: A) 50% by weight to 90% by weight, B) 0.01% by weight to 45% by weight, C) 0.01% by weight to 45% by weight, D) 0.1% by weight to 20% by weight, E) 0.1% by weight to 20% by weight. 8. The formulation according to claim 2 , wherein R 2 is H, and X is CH 2 —CH 2 wherein based on the total composition, the components are present as follows: A) 65% by weight to 85% by weight, B) 0.5% by weight to 10% by weight, C) 0.01% by weight to 10% by weight, D) 2% by weight to 15% by weight, and E) 2% by weight to 15% by weight. 9. The formulation according to claim 1 , wherein the at least one sphingolipid of the general formula I is formed by reaction of a sphinganine of the general formula II, wherein R 2 =H and X=CH 2 -CH 2 , with a second component selected from the group consisting of olive oil, castor oil, rapeseed oil, sesame oil, palm kernel oil, palm oil, almond oil, sorbitan monooleate, sorbitan monolaurate, sorbitan trioleate, soya oil, glycol distearate, and cetyltriglyceride.

Assignees

Inventors

Classifications

  • C12P13/02Primary

    Amides, e.g. chloramphenicol {or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes (peptides C12P21/00 or C07K)} · CPC title

  • Sphingolipids, e.g. ceramides, cerebrosides, gangliosides · CPC title

  • Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof · CPC title

  • Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals · CPC title

  • Preparations containing hair conditioners · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11939612B2 cover?
The invention provides a process for preparing sphingolipids, compositions comprising sphingolipids and further components, and for the use of the compositions.
Who is the assignee on this patent?
Evonik Operations Gmbh
What technology area does this patent fall under?
Primary CPC classification C12P13/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).